Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shanghai HeartCare Medical Technology Corporation Limited has scheduled a board meeting for August 30, 2024, to review and approve its interim financial results for the first half of the year and consider declaring an interim dividend. This announcement, which comes ahead of the board’s review, aims to keep shareholders informed of the upcoming financial decisions and potential dividend distributions.
For further insights into HK:6609 stock, check out TipRanks’ Stock Analysis page.